131 related articles for article (PubMed ID: 3438670)
1. Sickle cell anemia. Pathophysiological role of increased intracorpuscular calcium and changes during treatment with pentoxifylline.
Manrique R
Ric Clin Lab; 1987; 17(4):355-62. PubMed ID: 3438670
[TBL] [Abstract][Full Text] [Related]
2. Placebo controlled double-blind study of pentoxifylline in sickle cell disease patients.
Manrique RV
J Med; 1987; 18(5-6):277-91. PubMed ID: 3333162
[TBL] [Abstract][Full Text] [Related]
3. Pentoxifylline (Trental) has no significant effect on laboratory parameters in sickle cell disease.
Billett HH; Kaul DK; Connel MM; Fabry ME; Nagel RL
Nouv Rev Fr Hematol (1978); 1989; 31(6):403-7. PubMed ID: 2694097
[TBL] [Abstract][Full Text] [Related]
4. Studies on vasoocclusive crisis of sickle cell disease. I. Effect of pentoxifylline.
Ambrus JL; Ambrus CM; Gastpar H; Bannerman R; Bettigole R; Friedman S
J Med; 1979; 10(6):445-56. PubMed ID: 299453
[TBL] [Abstract][Full Text] [Related]
5. Studies on platelet aggregation with pentoxifylline: effect on neoplastic disorders and other new indications.
Ambrus JL; Ambrus CM; Gastpar H
J Med; 1979; 10(5):339-45. PubMed ID: 119023
[No Abstract] [Full Text] [Related]
6. Effect of pentoxifylline on sickle cell thalassaemia: haemorheological and clinical results.
Seiffge D; Berthold R; Berthold F
Klin Wochenschr; 1983 Nov; 61(22):1159-60. PubMed ID: 6656178
[TBL] [Abstract][Full Text] [Related]
7. Amelioration of blood viscosity in sickle cell anemia by pentoxifylline. A case report.
Keller F; Leonhardt H
J Med; 1979; 10(6):429-33. PubMed ID: 299452
[TBL] [Abstract][Full Text] [Related]
8. Studies on the vasoocclusive crisis of sickle cell disease IV. Mechanism of action of pentoxifylline (Trental).
Ambrus JL; Meky N; Stadler S; Sills RH; Gastpar H; Raposa T
J Med; 1988; 19(2):67-88. PubMed ID: 3171402
[TBL] [Abstract][Full Text] [Related]
9. Pentoxifylline inhibits granulocyte and platelet function, including granulocyte priming by platelet activating factor.
Hammerschmidt DE; Kotasek D; McCarthy T; Huh PW; Freyburger G; Vercellotti GM
J Lab Clin Med; 1988 Aug; 112(2):254-63. PubMed ID: 2840477
[TBL] [Abstract][Full Text] [Related]
10. [Improvement of blood viscosity in sickle-cell anaemia by pentoxifylline (author's transl)].
Keller F; Leonhardt H
Dtsch Med Wochenschr; 1980 Jun; 105(25):898-900. PubMed ID: 7408665
[TBL] [Abstract][Full Text] [Related]
11. A pilot study: an open clinical trial of pentoxiphylline in patients with painful sickle cell crises.
Khosla AA; Chintu C
East Afr Med J; 1984 Nov; 61(11):829-36. PubMed ID: 6399024
[No Abstract] [Full Text] [Related]
12. Treatment of sickle cell leg ulcers with pentoxifylline.
Frost ML; Treadwell P
Int J Dermatol; 1990 Jun; 29(5):375-6. PubMed ID: 2361798
[TBL] [Abstract][Full Text] [Related]
13. Hemorheological effects of pentoxifylline on disturbed flow behavior of blood in patients with cerebrovascular insufficiency.
Ott E; Lechner H; Fazekas F
Eur Neurol; 1983; 22 Suppl 1():105-7. PubMed ID: 6884401
[TBL] [Abstract][Full Text] [Related]
14. Beneficial results of pentoxifylline ('Trental') therapy in arteriosclerosis obliterans: possible mechanism of action.
Kostka-Trabkowa E; Dembińska-Kieć A; Grodzińska L; Bieroń K; Gryglewski RJ
Curr Med Res Opin; 1985; 9(6):407-15. PubMed ID: 3886306
[TBL] [Abstract][Full Text] [Related]
15. [Effectiveness of treatment during osteoarticular pain crises in drepanocytosis; based on the example of pentoxifylline].
Pichard E; Duflo B; Coulibaly S; Mariko B; Monsempes JL; Traore HA; Diallo AD
Bull Soc Pathol Exot Filiales; 1987; 80(5):834-40. PubMed ID: 3450443
[TBL] [Abstract][Full Text] [Related]
16. Pentoxifylline for sickle-cell disease.
Sherer JT; Glover PH
Ann Pharmacother; 2000 Sep; 34(9):1070-4. PubMed ID: 10981255
[TBL] [Abstract][Full Text] [Related]
17. Studies on the management and prevention of vasoocclusive crisis in sickle cell disease.
Ambrus JL; Ambrus CM; Bannerman R; Sills RH; Meky NN
J Med; 1984; 15(5-6):385-407. PubMed ID: 6100377
[TBL] [Abstract][Full Text] [Related]
18. Oxpentifylline and cetiedil citrate improve deformability of dehydrated sickle cells.
Stuart J; Stone PC; Bilto YY; Keidan AJ
J Clin Pathol; 1987 Oct; 40(10):1182-6. PubMed ID: 3119675
[TBL] [Abstract][Full Text] [Related]
19. [Chronic senile cerebrovascular insufficiency. Effects of suloctidil and pentoxifylline on erythrocyte deformability].
Pilla G; Ciaponi A; Migliavacca A; Bonora C
Ric Clin Lab; 1983; 13 Suppl 3():459-64. PubMed ID: 6324325
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of vaso-occlusive crisis of sickle-cell disease with pentoxifylline].
Clerc M; Doh-Egueli D; Chapuis F; Durin A; Bertrand Y; Souillet G; Philippe N
Pediatrie; 1989; 44(7):577-81. PubMed ID: 2812975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
